Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial.
Haddad TC, Suman VJ, Giridhar KV, Sideras K, Northfelt DW, Ernst BJ, O'Sullivan CC, Singh RJ, Desta Z, Peethambaram PP, Hobday TJ, Chumsri S, Leon-Ferre RA, Ruddy KJ, Yadav S, Taraba JL, Goodnature B, Goetz MP, Wang L, Ingle JN.
Haddad TC, et al. Among authors: singh rj.
Clin Cancer Res. 2024 May 16. doi: 10.1158/1078-0432.CCR-24-0341. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38752717